These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 4440427)
61. [Enzymatic and cytohormonal monitoring of endocrinologically threatened pregnancy]. Stanek J Folia Med Cracov; 1975; 17(4):365-79. PubMed ID: 770261 [No Abstract] [Full Text] [Related]
62. [Possibilities in evaluation of endocrine functions of the foetoplacental unit in risk pregnancies (author's transl)]. Donát J; Jirkalová V Cesk Gynekol; 1980 Jul; 45(6):371-8. PubMed ID: 7428059 [No Abstract] [Full Text] [Related]
63. Plasma oxytocinase and onset of labour. Mapa MK; Goswami SK; Devi PK; Mathur VS Indian J Med Res; 1974 Jun; 62(6):914-8. PubMed ID: 4474141 [No Abstract] [Full Text] [Related]
64. [Value of certain enzymological studies in the evaluation of placental function]. Kamiński K; Krupa B; Kaźmierczak W Wiad Lek; 1979 Sep; 32(18):1315-8. PubMed ID: 116427 [No Abstract] [Full Text] [Related]
65. [Role of oxytocinase (CAP) in prolonged pregnancy]. Kelm R; Chowaniec T Ginekol Pol; 1980 Mar; 51(3):229-33. PubMed ID: 7390243 [No Abstract] [Full Text] [Related]
66. [Further modification by Klimek of the chemical method of Tuppy and Nesvadba for determining cystyl aminopeptidase (oxytocinase) activity in the blood serum]. Nalepa I; Gadek K Ginekol Pol; 1986 Sep; 57(9):622-5. PubMed ID: 3803988 [No Abstract] [Full Text] [Related]
67. [Serum HPL, total estrogen excretion and serum oxytocinase in intrauterine retardation. Results of 3 evaluation procedures]. Kyank HR Zentralbl Gynakol; 1983; 105(10):635-41. PubMed ID: 6880465 [TBL] [Abstract][Full Text] [Related]
69. Serum cystyl aminopeptidase activity in the 36th week of pregnancy. Durham BH; Rewell RE J Clin Pathol; 1979 Apr; 32(4):318-20. PubMed ID: 447865 [TBL] [Abstract][Full Text] [Related]
70. [Dynamics of changes of oxytocinase activity in the blood during physiological and pathological pregnancy (author's transl)]. Vierik J; Bruchác D; Handzo I; Krizko M; Ponecová M Bratisl Lek Listy; 1980 Jul; 74(1):52-60. PubMed ID: 7397586 [No Abstract] [Full Text] [Related]
71. Prospects of the laboratory diagnosis of intrauterine foetal distress. Donát J; Jirkalová V Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(5):569-622. PubMed ID: 6972081 [No Abstract] [Full Text] [Related]
72. Plasma oxytocinase: the synthesis and biological properties of the first product of the degradation of oxytocin by this enzyme. Ferrier BM; Hendrie JM; Branda LA Can J Biochem; 1974 Jan; 52(1):60-6. PubMed ID: 4821072 [No Abstract] [Full Text] [Related]
73. [A rapid and clinically significant method for the determination of serum oxytocinase]. Brandl E; Semm K; Krieger W Arch Gynakol; 1975 Nov; 219(1-4):466-9. PubMed ID: 1243432 [No Abstract] [Full Text] [Related]
74. [Cystyl-aminopeptidase from human erythrocytes]. Alekseenko LP; Pozdnev VF; Orekhovich VN Dokl Akad Nauk SSSR; 1987; 293(3):728-31. PubMed ID: 3582124 [No Abstract] [Full Text] [Related]
75. Spectrophotometric end-point method for assay of serum cystyl-aminopeptidase in pregnancy. Durham BH Clin Chem; 1976 Jan; 22(1):79-82. PubMed ID: 1159 [TBL] [Abstract][Full Text] [Related]
76. CAP, HCS and urinary estriol measurements in risk pregnancies--a comparative study. Rydén G; Kågedal B J Perinat Med; 1977; 5(6):244-51. PubMed ID: 611164 [No Abstract] [Full Text] [Related]